DEBORA DE ARAUJO: Open Payments
NPI 1760155691 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,727 in 56 payments from 9 companies in 2025. Trend: 2023 $23 · 2024 $1,713 · 2025 $1,727
Food & beverage: $1,727
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $377 |
| AstraZeneca Pharmaceuticals LP | 5 | $296 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $273 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $254 |
| E.R. Squibb & Sons, L.L.C. | 3 | $167 |
| Novo Nordisk Inc | 3 | $159 |
| Novartis Pharmaceuticals Corporation | 14 | $147 |
| Medicure Pharma Inc. | 1 | $29 |
| Esperion Therapeutics, Inc. | 1 | $25 |
Products named: REPATHA, JARDIANCE, Kerendia, CAMZYOS, Wegovy, FARXIGA, LEQVIO, LOKELMA.
Industry payments across FL — which companies pay providers there.
